General Practice Doctors in Barksdale Afb, LA Accepting Medicare

3 General Practice doctors found. Showing 1 - 3

Matthew Scot Van Uitert, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 243 Curtiss Rd Ste 100, Barksdale Afb, LA 71110 Phone: 801-369-9354

Dr. Srikanth Choudary Lavu, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 243 Curtiss Rd Ste 100, Barksdale Afb, LA 71110 Phone: 318-529-4507

Dr. Thomas James Haycraft, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 243 Curtiss Rd Ste 100, Barksdale Afb, LA 71110 Phone: 318-456-4470    Fax: 318-456-7012

News Archive

Study: Rural Americans are less likely to follow COVID-19 prevention behaviors

Timothy Callaghan, PhD, and Alva Ferdinand, DrPH, JD, from the Southwest Rural Health Research Center at Texas A&M University School of Public Health, joined colleagues in the first national study of how often people in urban and rural areas in the United States follow COVID-19 guidelines

Researchers compare lipid-lowering efficacy for two nonstatin therapies in statin-intolerant patients

Steven E. Nissen, M.D., of the Cleveland Clinic, and colleagues identified patients with muscle-related adverse effects from statins and compared lipid-lowering efficacy for two nonstatin therapies, ezetimibe and evolocumab. The study was published online by JAMA, and is being released to coincide with its presentation at the American College of Cardiology's 65th Annual Scientific Session & Expo.

Innovative approach for creating a cytomegalovirus vaccine

Each year, about 40,000 children are born infected with human cytomegalovirus, or CMV, and about 8,000 of these children suffer permanent disabilities due to the virus - almost one an hour.

Preliminary study suggests nitric oxide may be a potential treatment for COVID-19 respiratory failure

New research led by Devang K. Sanghavi of the Mayo Clinic in Florida, USA, suggests pre-intubation use of nitric oxide for patients with COVID-19–related hypoxemic respiratory may help reduce patients' mortality. Their findings show that inhaling nitric oxide in this patient population could reduce the need for future intubation and other invasive mechanical ventilation.

Shire to enter European ADHD market with acquisition of EQUASYM IR and XL

Shire plc has announced that it has signed an agreement with UCB to acquire the worldwide rights to EQUASYM IR and XL (methylphenidate hydrochloride) (excluding the USA, Canada and Barbados) used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

Read more Medical News

› Verified 7 days ago